Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery

American Journal of Health-System Pharmacy

Volumn 63, Issue 17, 2006, Pages 1637-1640

  Jensen, Michael K ^a,b   Fiscella, Richard G ^c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; GATIFLOXACIN; MOXIFLOXACIN; POLYTRIM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

AMBULATORY SURGERY; ARTICLE; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG FORMULARY; EYE SURGERY; HUMAN; MEDICAL LITERATURE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROBLEM SOLVING; PUBLICATION;

EID: 33748773937     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050523     Document Type: Article

References (17)

1. Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol. 2004; 49(suppl 2):S79-83.
2. Smith A, Pennefather PM, Kaye SB et al. Fluoroquinolones: place in ocular therapy. Drugs. 2001; 61:747-61.
3. Kowalski RR, Dhaliwal DK, Karenchak LM et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 2003; 136:500-5.
4. Jensen MK, Fiscella RG, Lewis CC. Using an infection-reporting database to improve outcomes in cataract-surgery patients. Am J Health-Syst Pharm. 2004; 61:198-201.
5. Jensen MK, Fiscella RG, Crandall AS et al. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol. 2005; 139:141-8.
6. Fiscella R, Green A, Patuszynski DH et al. Medical therapy cost considerations for glaucoma. Am J Ophthalmol. 2003; 136:18-25.
7. Baum J, Barza M. The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1997-2000. Cornea. 2000; 19:659-72.
8. Teoh DL, Reynolds S. Diagnosis and management of pediatric conjunctivitis. Pediatr Emerg Care. 2003; 19:48-55.
9. David SP. Should we prescribe antibiotics for acute conjunctivitis? Am Fam Physician. 2002; 66:1649-50.
10. Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: a systematic review. Br J Gen Pract. 2001; 51:473-7.
11. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol. 1995; 113:1479-96.
12. Winthrop KL, Steinberg EB, Holmes G et al. Epidemic and sporadic cases of nontuberculous mycobacterial keratitis associated with laser in situ keratomileusis. Am J Ophthalmol. 2003; 135:223-4.
13. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000; 107:1497-502.
14. Chaudhry NA, Flynn HW Jr, Murray TG et al. Emerging ciprofloxacin- resistant Pseudomonas aeruginosa. Am J Ophthalmol. 1999; 128:509-10.
15. Garg P, Sharma S, Rao GN. Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology. 1999; 106:1319-23.
16. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999; 106:1313-8.
17. Kowalski R, Karenchak LM, Romanowski EG. Infectious disease: changing antibiotic susceptibility. Ophthalmol Clin North Am. 2003; 16:1-9.